AR and breast cancer: Concerning non-luminal BC, it was reported that in a subset of triple-negative tumors, namely luminal AR-positive tumors (LAR), FOXA1 induces AR function, resulting in an estrogen-induced-like proliferation, by directing AR to sites normally ER-occupied in luminal tumors [5,6,7,8].